AstraZeneca confirmed Wednesday that his COVID-19 vaccine was very effective in preventing disease.
The Anglo-Swedish drugmaker has confirmed this based on more recent data after questions were raised about the interim results of its US clinical trial findings announced on Monday.
Key Comments:
“Positive results from the primary analysis of the phase III trial of AZD1222 in the US have confirmed the efficacy of the COVID vaccine.”
“The vaccine was well tolerated and no safety concerns were identified“.
“There are 76% efficacy of the symptomatic covid vaccine“.
.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
